PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-04-18

Date Title Company
18-Apr-2023 Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference Businesswire
18-Apr-2023 Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023 Businesswire
18-Apr-2023 Carbios beschleunigt Enzymoptimierung mit einer erhöhten Screening-Kapazität von mehreren Millionen Enzymen pro Tag Businesswire
18-Apr-2023 Carbios Accelerates Its Enzyme Optimization With Screening Capabilities for Millions of Enzymes in a Day Businesswire
18-Apr-2023 Capable de cribler des millions d’enzymes en un jour, Carbios démultiplie ses capacités d’optimisation d’enzymes Businesswire
18-Apr-2023 The value of Insulin Pump Market is projected to increase at a CAGR of around 10.3% through 2032 MARKITWIRED
18-Apr-2023 Surgical Mask Market is expected to hold a share of US$ 5.7 billion by 2033, with a CAGR of 10.7% MARKITWIRED
18-Apr-2023 Vision Care Market might be valued at US$ 169.37 billion in 2032, with a CAGR of 7.3% MARKITWIRED
18-Apr-2023 Cell Therapy Manufacturing Market is expected to reach US$ 13.9 Billion by 2032 and exhibit growth at a CAGR of 14.2% MARKITWIRED
18-Apr-2023 CNS Treatment and Therapy Market is anticipated to reach US$ 205.3 billion by 2033, at a CAGR 5.2% MARKITWIRED
18-Apr-2023 SMART introduces three research initiatives to revolutionise diagnostic capabilities for health applications Blue Totem Communications
18-Apr-2023 Pharmaceutical Industry Needs More Cross-Sector Collaboration Sciad Newswire
18-Apr-2023 Biophytis Announces 2022 Financial Results and 2023 Perspectives Biophytis
18-Apr-2023 Sexually Transmitted Diseases Diagnostics Market is likely to reach US$ 6.4 Billion by 2032 | Exclusive Report by FMI MARKITWIRED
18-Apr-2023 Dental Laboratories Market is expected to reach US$ 53.74 Billion by the end of 2032 | FMI Study MARKITWIRED
18-Apr-2023 Retractable Needle Safety Syringes Market is likely to grow at a steady CAGR of 4.0% between 2022 and 2032 | FMI MARKITWIRED
18-Apr-2023 Chronic Disease Management Market is likely to advance at 13.4% CAGR (2022-2032). MARKITWIRED
18-Apr-2023 Autism Spectrum Disorder Management Market is expected to grow at a 5.3% CAGR and secure US$ 3.7 Billion by 2032 MARKITWIRED
18-Apr-2023 Aarskog Scott Syndrome Treatment Market value of US$ 6 Billion by registering a CAGR of 6.5% in the forecast period 2023 to 2033 MARKITWIRED
18-Apr-2023 Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study Spexis AG